Real-time enrollment status for this extrapulmonary neuroendocrine cancer (epnec) clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 11:34 AM UTC
| NCT Number | NCT07544654 |
| Recruiting Status | Recruiting |
| Condition | Extrapulmonary Neuroendocrine Cancer (epNEC) |
| Phase | PHASE3 |
| Target Enrollment | 390 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | September 2, 2026 (4 days ago) |
As of September 6, 2026: Clinical trial NCT07544654 is currently recruiting participants. This phase3 study for extrapulmonary neuroendocrine cancer (epnec) is actively seeking new participants at 20 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07544654 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07544654 was last updated 4 days ago (September 2, 2026). HelloStudys verifies this status automatically.